Disease progression, drug action and Parkinson’s disease: Why time cannot be ignored
Author:
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Pharmacology,General Medicine
Link
http://link.springer.com/content/pdf/10.1007/s00228-007-0427-9.pdf
Reference25 articles.
1. Nutt JG, Holford NHG (1996) The response to levodopa in Parkinson’s disease: Imposing pharmacological law and order. Ann Neurol 39:561–573
2. Chan PL, Nutt JG, Holford NH (2005) Importance of within subject variation in levodopa pharmacokinetics: a 4 year cohort study in Parkinson’s disease. J Pharmacokinet Pharmacodyn 32(3–4):307–331, Aug
3. Chan PL, Nutt JG, Holford NH (2005) Pharmacokinetic and pharmacodynamic changes during the first four years of levodopa treatment in Parkinson’s disease. J Pharmacokinet Pharmacodyn 32(3–4):459–484, Aug
4. Chan PL, Nutt JG, Holford NH (2007) Levodopa slows progression of Parkinson’s disease. External validation by clinical trial simulation. Pharm Res 24(4):791–802, Apr
5. Chan PLS, Nutt JG, Holford NHG (2004) Modeling the short and long duration responses to exogenous levodopa and to endogenous levodopa production in Parkinson’s disease. J Pharmacokinet Pharmacodyn 31(3):243–268
Cited by 36 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Modeling of Parkinson’s Disease Progression and Implications for Detection of Disease Modification in Treatment Trials;Journal of Parkinson's Disease;2024-09-03
2. Biosensors for Parkinson’s Disease: Where Are We Now, and Where Do We Need to Go?;ACS Sensors;2024-08-27
3. Prediction of Individual Disease Progression Including Parameter Uncertainty in Rare Neurodegenerative Diseases: The Example of Autosomal-Recessive Spastic Ataxia Charlevoix Saguenay (ARSACS);The AAPS Journal;2024-04-30
4. Longitudinal Meta‐Analysis of Historical Parkinson's Disease Trials to Inform Future Trial Design;Movement Disorders;2023-07-03
5. Convolutional neural network reveals frequency content of medio-lateral COM body sway to be highly predictive of Parkinson’s disease;2023-05-30
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3